Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma 2024-09-04 08:00
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 2024-09-04 06:57
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays 2024-09-02 21:00
Frost & Sullivan Released Report: "BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies" 2024-09-02 17:20
Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024 2024-09-02 08:23
Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI®(encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation 2024-08-30 20:44
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations 2024-08-30 11:01
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms 2024-08-29 20:42
LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital 2024-08-29 10:00
Necessary Care or Abuse? Unpacking the Reason Behind Overprescription 2024-08-29 08:30
Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024 2024-08-29 08:00
Innovent Announces 2024 Interim Results and Business Updates 2024-08-28 18:42
Everest Medicines Announces Interim Results for First Half of 2024 2024-08-28 08:00
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent 2024-08-28 07:53
Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market 2024-08-28 00:00
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases by RMB 180 Million 2024-08-27 22:55
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study 2024-08-27 20:05
JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-08-27 17:00
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment 2024-08-27 09:00
1 7 8 9 10 11 248